Biotech companies are seeing significant pre-market activity this Thursday.
Price swings before the opening bell today are being driven by FDA panel decisions, second-quarter financial results and offerings.
In the Green - Premarket Gainers
On Thursday, the following biotech stocks were trading significantly higher in the premarket session.
1. Nuwellis, Inc. (NUWE) - up 125% at $4.24 2. China SXT Pharmaceuticals, Inc. (SXTC) - up 44% at $0.073. GlucoTrack, Inc. (GCTK) - up 40% at $-0.394. Corcept Therapeutics Incorporated. (CORT) - up 18% at $109.625. Mobile-health Network Solution. (MNDR) - up 14% at $1.656. SL Science Holding Ltd. (SLBT) - up 14% at $2.957. Sanara MedTech Inc. (SMTI) - up 10% at $33.41 8. Milestone Scientific Inc. (MLSS) - up 8% at $0.40 9. Imunon, Inc. (IMNN) - up 7% at $1.65 10. ImmunityBio, Inc. (IBRX) - up 6% at $7.27
For comments and feedback contact: editorial@rttnews.com
Economic News
What parts of the world are seeing the best (and worst) economic performances lately? Click here to check out our Econ Scorecard and find out! See up-to-the-moment rankings for the best and worst performers in GDP, unemployment rate, inflation and much more.
September 04, 2026 15:08 ET The job report and foreign trade data were the main economic news from the U.S. in the first week of September. Elsewhere in North America, the Canadian central bank announced its latest policy decision. Inflation data from Eurozone was the highlight in Europe. The latest interest rate decision by the Reserve Bank of New Zealand drew attention in Asia.